Genomic rearrangement of cytokine receptor-like factor 2 (CRLF2) has been reported to be associated with JAK kinases mutations in childhood B-ALL cases, including DS patients [72, 73]. Here, CRLF2 is linked to acute lymphoblastic leukemia.